Evidence map›Paper›PMID 35759175›Full record

SynthesisCurrent pain and headache reports2022

Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.

Sakari Santeri Rusanen, Suchetana De, Emmanuelle Andree Danielle Schindler, Ville Aleksi Artto, Markus Storvik

Abstract readSystematic Review
In one paragraph

Synthesis in Current pain and headache reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Associations between psychedelic use and migraine history in Swedish twins.Journal of psychopharmacology (Oxford, England) · 2026
    Article
  2. Article
  3. Psilocybin for clinical indications: A scoping review.Journal of psychopharmacology (Oxford, England) · 2024
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sakari Santeri RusanenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Suchetana DeSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0001-6341-3337
Emmanuelle Andree Danielle SchindlerDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-7962-0365
Ville Aleksi ArttoDepartment of Neurology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-2258-9146
Markus StorvikSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland. markus.storvik@uef.fi.ORCID http://orcid.org/0000-0003-4186-6313

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

purpose of reviewThe use and efficacy of various substances in the treatment of CH have been studied in several retrospective surveys. The aim of the study is to systematically review published survey studies to evaluate the reported efficacies of both established and unconventional substances in abortive and prophylactic treatment of both episodic and chronic CH, specifically assessing the consistency of the results. RECENT

findingsNo systematic review have been conducted of these studies previously. A systematic literature search with a set of search terms was conducted on PubMed. Retrospective surveys that quantified the self-reported efficacy of two or more CH treatments, published in English during 2000-2020, were included. Several key characteristics and results of the studies were extracted. A total of 994 articles were identified of which 9 were found to be eligible based on the selection criteria. In total, 5419 respondents were included. Oxygen and subcutaneous triptan injections were most reported as effective abortive treatments, while psilocybin and lysergic acid diethylamide were most commonly reported as effective prophylactic treatments. The reported efficacy of most substances was consistent across different studies, and there were marked differences in the reported efficacies of different substances. The reported order of efficacy is generally in agreement with clinical studies. The findings suggest that retrospective surveys can be used to obtain supporting information on the effects of various substances used in the treatment of CH and to form hypotheses about novel treatment methods. The consistently reported efficacy of psilocybin and LSD in prophylactic treatment indicates need for clinical studies.

Indexed as

Cluster HeadachePsilocybinHumansLysergic Acid DiethylamideRetrospective StudiesSelf ReportSurveys and QuestionnairesLysergic Acid DiethylamidePsilocybinClusterComparisonEfficacyHeadacheReviewSurvey

Identifiers

PMID35759175
PMCPMC9436841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.